The radiosynthesis, as well as the in vivo and ex vivo biodistribution of the 11 C radiolabelled 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime ( 6 , [ 11 C]SZV 1287) are reported. SZV 1287 is a novel SSAO inhibitor and a promising candidate to be a novel analgesic for the treatment of neuropathic